A coalition of health advocacy organizations is suing the Trump administration over its rollout of a program allowing doctors to distribute marijuana products to Medicare Advantage patients.
The lawsuit, filed Monday in the US District Court for the District of Columbia by 11 marijuana opposition groups, alleges the program was announced by the Centers for Medicare & Medicaid Services without undergoing the required notice-and-comment rulemaking procedures, depriving interested parties of their ability to voice their concerns.
“CMS took this action without the guardrails imposed by the administrative process, without any reasoned explanation, in conflict with the agency’s own recent ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.